Latini R - Search Results

1

Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS.

Piotti A, Novelli D, Meessen JMTA, Ferlicca D, Coppolecchia S, Marino A, Salati G, Savioli M, Grasselli G, Bellani G, Pesenti A, Masson S, Caironi P, Gattinoni L, Gobbi M, Fracasso C, Latini R; ALBIOS Investigators. Piotti A, et al. Among authors: latini r. Crit Care. 2021 Mar 19;25(1):113. doi: 10.1186/s13054-021-03545-1. Crit Care. 2021. PMID: 33741039 Free PMC article. Clinical Trial.

2

[Refractory heart failure. Antagonism of tumor necrosis factor alpha and endothelin in humans: 2 promises still to be honored].

Valgimigli M, Ferrari R, Masson S, Latini R. Valgimigli M, et al. Among authors: latini r. Ital Heart J Suppl. 2002 Aug;3(8):793-803. Ital Heart J Suppl. 2002. PMID: 12407834 Review. Italian.

3

Role of brain natriuretic peptide in the diagnosis and management of heart failure: current concepts.

Latini R, Masson S, de Angelis N, Anand I. Latini R, et al. J Card Fail. 2002 Oct;8(5):288-99. doi: 10.1054/jcaf.2002.0805288. J Card Fail. 2002. PMID: 12411979 Review.

4

Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat.

De Angelis N, Fiordaliso F, Latini R, Calvillo L, Funicello M, Gobbi M, Mennini T, Masson S. De Angelis N, et al. Among authors: latini r. J Mol Cell Cardiol. 2002 Dec;34(12):1655-65. doi: 10.1006/jmcc.2002.2115. J Mol Cell Cardiol. 2002. PMID: 12505063

5

Valsartan for the treatment of heart failure.

Latini R, Masson S, Staszewsky L, Maggioni AP. Latini R, et al. Expert Opin Pharmacother. 2004 Jan;5(1):181-93. doi: 10.1517/14656566.5.1.181. Expert Opin Pharmacother. 2004. PMID: 14680446 Review.

6

The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN; Val-HeFT Investigators. Latini R, et al. Eur Heart J. 2004 Feb;25(4):292-9. doi: 10.1016/j.ehj.2003.10.030. Eur Heart J. 2004. PMID: 14984917 Clinical Trial.

7

Myocardial infarction: animal models.

Chimenti S, Carlo E, Masson S, Bai A, Latini R. Chimenti S, et al. Among authors: latini r. Methods Mol Med. 2004;98:217-26. doi: 10.1385/1-59259-771-8:217. Methods Mol Med. 2004. PMID: 15064443

8

Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.

Latini R, Masson S, Wong M, Barlera S, Carretta E, Staszewsky L, Vago T, Maggioni AP, Anand IS, Tan LB, Tognoni G, Cohn JN; Val-HeFT Investigators. Latini R, et al. Am J Med. 2006 Jan;119(1):70.e23-30. doi: 10.1016/j.amjmed.2005.08.041. Am J Med. 2006. PMID: 16431191

9

The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT).

Masson S, Latini R, Anand IS, Barlera S, Judd D, Salio M, Perticone F, Perini G, Tognoni G, Cohn JN; Val-HeFT investigators. Masson S, et al. Among authors: latini r. J Card Fail. 2006 Jun;12(5):375-80. doi: 10.1016/j.cardfail.2006.02.013. J Card Fail. 2006. PMID: 16762801

10

Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data.

Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN; Val-HeFT Investigators. Masson S, et al. Among authors: latini r. Clin Chem. 2006 Aug;52(8):1528-38. doi: 10.1373/clinchem.2006.069575. Epub 2006 Jun 15. Clin Chem. 2006. PMID: 16777915 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

527 results

Search Page